The Microbiome and Disease Tolerance Centre (MDTC) at McGill is an advanced research and education centre working in the area of human health and how the microbes normally present in our bodies, the so called commensal and long term low pathogenic microbes, can determine our immune health status and prevent or cause the development of chronic, immune-mediated inflammatory diseases. MDTC at McGill University is a research group that promotes and carries out advanced research and education on fundamental mechanisms that govern the interactions between microbes and the healthy human body. The MDTC will explore how these interactions maintain human health and how they help us to avoid commonly observed diseases.
This proposal is driven by a group of 25 investigators from 3 universities (McGill, Montréal, McMaster), based on 3 Faculties at McGill (Medicine, Science and Agricultural and Environmental Sciences) and 5 departments (Microbiology and Immunology, Medicine, Paediatrics, Human Genetics, Institute of Parasitology), to synergize their own internationally renowned research programs into an innovative health research opportunity for McGill, the province of Quebec, Canada and beyond.
MDTC will become a global leader in research and education in the area of microbial – immune interactions providing answers to questions regarding our health such as: what makes microbes helpful or harmful? How can microbes in our bodies make us healthy or sick? How can we promote healthy immunity? And how can we prevent inflammatory and immune diseases such as diabetes, multiple sclerosis or infections?